Cholera Vaccines Market 2030 Revenue, Top Key Drivers by Manufacturers and Outlook
The global cholera vaccine market was valued at USD 93.9 million in 2024 and is projected to reach USD 163.4 million by 2030, expanding at a healthy CAGR of 10.0% from 2025 to 2030. Cholera, caused by Vibrio cholerae, continues to be a major public health threat in endemic regions, particularly where access to clean water and proper sanitation is limited. Vaccines have become a critical preventive tool, and the availability of both oral and injectable formulations provides flexibility for use in different population groups and health settings. Market growth is strongly supported by increasing awareness of cholera outbreaks in endemic regions and the proactive efforts of international health organizations, governments, and NGOs to control the disease. Strengthened vaccination campaigns and mass immunization drives have been launched to minimize outbreaks, while persistent research efforts and technological advancements are expected to enhance vaccine efficacy, impro...